Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
IbafloxacinPDL I DEC / 13
Ibandronic acid and its saltsF1 I SEP / 06
Ibogaine or its salts or derivatives or analoguesPDL I MAY / 17
Ibrutinib or its saltsPDL I DEC / 14
Ibuprofen or its saltsPDL

except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide and its salts and derivativesF1 I DEC / 02
Icatibant or its saltsPDL

including but not limited to Icatibant acetate

I AUG / 14
Idarubicin and its saltsF1 I SEP / 98
IdarucizumabPDL I AUG / 16
IdebenonePDL I DEC / 13
IdelalisibPDL I MAY / 15
IdoxuridineF1 I SEP / 98
IdursulfaseFR I FEB / 09
IfosfamideF1 I SEP / 98
Imatinib and its saltsF1 I OCT / 03
ImigluceraseF1 I SEP / 98
Imipenem and its salts and derivativesF1 I SEP / 98
Imipramine and its saltsF1 I SEP / 98
Imiquimod and its saltsF1 I MAY / 00
Immune globulin products I FEB / 02
Indacaterol or its salts or derivativesPDL I DEC / 13
Indapamide and its saltsF1 I SEP / 98
Indinavir and its saltsF1 I SEP / 98
IndomethacinF1 I SEP / 98
InfliximabF1 I JUL / 03
Influenza vaccine II DEC / 98
Inhaled human insulinF1 I JUN / 08
Inhaled human insulin.F1 I DEC / 08
InosiplexF1 I SEP / 98
Inositol niacinate U DEC / 98
InsulinD II SEP / 98
InterferonF1 I SEP / 98
Invermectin and its derivatives, for human use or for veterinary useF1 when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodine and its salts and derivatives for topical use III SEP / 98
Iodochlorhydroxyquin for topical use II SEP / 98
IodochlorohydroxyquinF1 except in preparations for topical use on the skin I SEP / 98
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
Ipecac and its extracts and derivatives. for use other than as an emetic U OCT / 98
IpilimumabPDL I DEC / 13
Ipratropium and its saltsF1 I SEP / 98
Iproniazid and its saltsF1 I SEP / 98
Irbesartan and its saltsF1 I SEP / 99
Irinotecan and its saltsF1 I SEP / 98
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron and its salts and derivatives. in preparations containing 30 mg or less elemental iron per solid dosage unit or 5 ml oral liquid U
Iron derivativesPDL

for human use, including but not limited to ferumoxytol for parenteral use only

I DEC / 13
Iron derivativesPDL

for veterinary use, including but not limited to ferumoxytol for all routes of administration but parenteral

I DEC / 13
Isocarboxazid and its saltsF1 I SEP / 98
IsofluraneF1 I SEP / 98
IsomethadoneN I JUN / 02
IsoniazidF1 I SEP / 98
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
IsoproterenolF1 Isoprenaline and its salts I SEP / 98
Isosorbide and its salts I SEP / 98
Isotretinoin and its saltsF1 I SEP / 98
Isoxsuprine and its saltsF1 I SEP / 98
Isradipine and its saltsF1 I SEP / 98
Itraconazole and its saltsF1 I SEP / 98
Ivabradine or its salts or derivativesPDL I FEB / 17
Ivermectin and its derivativesF1 for human use or for veterinary use when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Ixazomib or its derivativesPDL I NOV / 16
IxekizumabPDL I AUG / 16

68 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled